Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Receives Average Recommendation of “Hold” from Analysts

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRXGet Rating) has been given a consensus rating of “Hold” by the nine analysts that are covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is $21.80.

A number of research firms have recently issued reports on MDRX. The Goldman Sachs Group began coverage on Allscripts Healthcare Solutions in a report on Tuesday, July 12th. They issued a “neutral” rating and a $21.00 target price for the company. Piper Sandler dropped their target price on Allscripts Healthcare Solutions from $19.00 to $17.00 in a report on Thursday, June 9th. Finally, KeyCorp assumed coverage on shares of Allscripts Healthcare Solutions in a report on Thursday, September 15th. They set a “sector weight” rating for the company.

Allscripts Healthcare Solutions Trading Up 0.8 %

NASDAQ:MDRX opened at $16.70 on Friday. The stock has a fifty day simple moving average of $16.49 and a 200 day simple moving average of $18.06. The company has a quick ratio of 3.23, a current ratio of 3.23 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $1.85 billion, a price-to-earnings ratio of 38.84, a price-to-earnings-growth ratio of 1.55 and a beta of 0.98. Allscripts Healthcare Solutions has a 1-year low of $13.05 and a 1-year high of $23.25.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last released its earnings results on Thursday, August 4th. The software maker reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.03. The business had revenue of $150.90 million for the quarter, compared to the consensus estimate of $148.58 million. Allscripts Healthcare Solutions had a net margin of 5.90% and a return on equity of 10.62%. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period last year, the firm posted $0.17 earnings per share. Sell-side analysts forecast that Allscripts Healthcare Solutions will post 0.66 earnings per share for the current year.

Insider Activity at Allscripts Healthcare Solutions

In other Allscripts Healthcare Solutions news, CFO Leah Jones sold 3,921 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $17.65, for a total value of $69,205.65. Following the completion of the sale, the chief financial officer now directly owns 109,055 shares in the company, valued at $1,924,820.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Richard J. Poulton sold 10,000 shares of the stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $17.46, for a total transaction of $174,600.00. Following the transaction, the chief executive officer now owns 742,517 shares of the company’s stock, valued at approximately $12,964,346.82. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Leah Jones sold 3,921 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $17.65, for a total value of $69,205.65. Following the completion of the transaction, the chief financial officer now directly owns 109,055 shares in the company, valued at $1,924,820.75. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,945 shares of company stock valued at $360,569. 2.29% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. C M Bidwell & Associates Ltd. bought a new position in Allscripts Healthcare Solutions during the first quarter worth $44,000. MQS Management LLC acquired a new position in shares of Allscripts Healthcare Solutions during the second quarter valued at about $154,000. Prelude Capital Management LLC bought a new stake in shares of Allscripts Healthcare Solutions in the second quarter valued at about $156,000. AdvisorShares Investments LLC acquired a new stake in Allscripts Healthcare Solutions during the first quarter worth about $186,000. Finally, Inspire Investing LLC increased its stake in Allscripts Healthcare Solutions by 37.9% during the second quarter. Inspire Investing LLC now owns 14,360 shares of the software maker’s stock valued at $213,000 after acquiring an additional 3,943 shares during the period. 99.76% of the stock is currently owned by institutional investors and hedge funds.

About Allscripts Healthcare Solutions

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.